Last updated at 18 May 2025 04:03 PM
Director
DIN: 09744384
Anju Bala is currently associated with 3 companies in various capacities such as Director and Non- Individual Subscriber. They serve as a Director at OZONE PHARMACEUTICALS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09744384.Anju Bala is currently involved in 2 different roles. Their most recent position is with OZONE HEALTH AND LIFESCIENCES PRIVATE LIMITED as a Non- Individual Subscriber. The first company Anju Bala was appointed to as a director was OZONE PHARMACEUTICALS LIMITED. Anju Bala is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Anju Bala is currently associated with 3 companies in various capacities such as Director and Non- Individual Subscriber. They serve as a Director at OZONE PHARMACEUTICALS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09744384.Anju Bala is currently involved in 2 different roles. Their most recent position is with OZONE HEALTH AND LIFESCIENCES PRIVATE LIMITED as a Non- Individual Subscriber. The first company Anju Bala was appointed to as a director was OZONE PHARMACEUTICALS LIMITED. Anju Bala is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Female
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
8 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| OZONE PHARMACEUTICALS LIMITED | Director | 21-Sep-2022 |
| 4THD PHARMA PRIVATE LIMITED | Director | 28-Aug-2024 |
| OZONE HEALTH AND LIFESCIENCES PRIVATE LIMITED | Non- Individual Subscriber | 16-Apr-2025 |
| OZONE HEALTH AND LIFESCIENCES PRIVATE LIMITED | Director | 16-Apr-2025 |